PL4240348T3 - Pochodne 2-[tiofen-2-ylo)formamido]-n-(fenylo)-2-metylopropanoamidu i ich zastosowanie jako lek - Google Patents

Pochodne 2-[tiofen-2-ylo)formamido]-n-(fenylo)-2-metylopropanoamidu i ich zastosowanie jako lek

Info

Publication number
PL4240348T3
PL4240348T3 PL21801942.0T PL21801942T PL4240348T3 PL 4240348 T3 PL4240348 T3 PL 4240348T3 PL 21801942 T PL21801942 T PL 21801942T PL 4240348 T3 PL4240348 T3 PL 4240348T3
Authority
PL
Poland
Prior art keywords
formamido
thiophen
medicament
phenyl
methylpropanamide
Prior art date
Application number
PL21801942.0T
Other languages
English (en)
Inventor
Stephan Georg Mueller
Kelly ALLERS
Klaus Klinder
Ursula Mueller-Vieira
Henning Priepke
Alexander Pautsch
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of PL4240348T3 publication Critical patent/PL4240348T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL21801942.0T 2020-11-06 2021-11-04 Pochodne 2-[tiofen-2-ylo)formamido]-n-(fenylo)-2-metylopropanoamidu i ich zastosowanie jako lek PL4240348T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20206286 2020-11-06
PCT/EP2021/080572 WO2022096542A1 (en) 2020-11-06 2021-11-04 2-[thiophen-2-yl)formamido]-n-(phenyl)-2-methylpropanamide derivatives and the use thereof as medicament

Publications (1)

Publication Number Publication Date
PL4240348T3 true PL4240348T3 (pl) 2026-07-20

Family

ID=73198096

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21801942.0T PL4240348T3 (pl) 2020-11-06 2021-11-04 Pochodne 2-[tiofen-2-ylo)formamido]-n-(fenylo)-2-metylopropanoamidu i ich zastosowanie jako lek

Country Status (10)

Country Link
US (1) US11691960B2 (pl)
EP (1) EP4240348B1 (pl)
JP (1) JP7502564B2 (pl)
CN (1) CN116406266B (pl)
AR (1) AR124022A1 (pl)
DK (1) DK4240348T3 (pl)
ES (1) ES3068139T3 (pl)
PL (1) PL4240348T3 (pl)
TW (1) TW202233588A (pl)
WO (1) WO2022096542A1 (pl)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022432A1 (en) * 1996-11-18 1998-05-28 Yamanouchi Pharmaceutical Co., Ltd. Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
US7058024B1 (en) 1999-02-03 2006-06-06 Lucent Technologies, Inc. Automatic telecommunications link identification system
WO2005111014A1 (de) 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Substituierte thiophencarbonsäureamide, deren herstellung und deren verwendung als arzneimittel
WO2005111013A1 (de) 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Substituierte thiophen-2-carbonsäureamide, deren herstellung und deren verwendung als arzneimittel
KR20070012552A (ko) 2004-05-13 2007-01-25 베링거 인겔하임 인터내셔날 게엠베하 신규한 치환된 티오펜카복스아미드, 이의 제조방법 및약제로서의 이의 용도
DE102004047840A1 (de) 2004-09-29 2006-03-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Thiophencarbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel
PE20070171A1 (es) 2005-06-30 2007-03-08 Boehringer Ingelheim Int GLICINAMIDAS SUSTITUIDAS CON EFECTO ANTITROMBOTICO E INHIBIDOR DEL FACTOR Xa
CN101843618A (zh) * 2010-02-26 2010-09-29 复旦大学 小檗碱及其衍生物在制备吲哚胺2,3-双加氧酶抑制剂中的用途
US9365588B2 (en) * 2011-11-04 2016-06-14 Vertex Pharmaceuticals Incorporated Benzoxazines as modulators of ion channels
US20150196533A1 (en) * 2012-07-02 2015-07-16 The General Hospital Corporation Method for concurrent treatment of pain and depression
EA029981B1 (ru) * 2013-08-27 2018-06-29 Бристол-Майерс Сквибб Компани Ингибиторы ido
WO2018069842A1 (en) * 2016-10-14 2018-04-19 Pi Industries Ltd 4-amino substituted phenylamidine derivatives and their use to protect crops by fighting undesired phytopathogenic micoorganisms
US11370761B2 (en) * 2017-01-23 2022-06-28 Nippon Chemiphar Co., Ltd. Voltage-dependent T-type calcium channel inhibitor
WO2019087028A1 (en) * 2017-10-30 2019-05-09 Glaxosmithkline Intellectual Property Development Limited Modulators of indoleamine 2,3-dioxygenase

Also Published As

Publication number Publication date
EP4240348B1 (en) 2026-02-11
AR124022A1 (es) 2023-02-01
US20220144796A1 (en) 2022-05-12
WO2022096542A1 (en) 2022-05-12
TW202233588A (zh) 2022-09-01
US11691960B2 (en) 2023-07-04
DK4240348T3 (da) 2026-04-20
CN116406266B (zh) 2026-07-10
EP4240348A1 (en) 2023-09-13
CN116406266A (zh) 2023-07-07
ES3068139T3 (es) 2026-05-27
JP7502564B2 (ja) 2024-06-18
JP2023547529A (ja) 2023-11-10